{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T19:56:52Z","timestamp":1771963012635,"version":"3.50.1"},"reference-count":79,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.joca.2013.08.001","type":"journal-article","created":{"date-parts":[[2013,8,13]],"date-time":"2013-08-13T20:05:24Z","timestamp":1376424324000},"page":"1813-1823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of\u00a0metabolic inflammation"],"prefix":"10.1016","volume":"21","author":[{"given":"V.","family":"Opoka-Winiarska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Jurecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Emeryk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tylki-Szyma\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2013.08.001_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00431-012-1703-y","article-title":"Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls","volume":"171","author":"Burton","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.joca.2013.08.001_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.joca.2013.08.001_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10545-011-9410-9","article-title":"Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP)","volume":"36","author":"Hendriksz","year":"2013","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.joca.2013.08.001_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1750-1172-7-22","article-title":"Capturing phenotypic heterogeneity in MPS I: results of an international consensus procedure","volume":"7","author":"de Ru","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.joca.2013.08.001_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.22092","article-title":"Mucopolysaccharidosis type IIIA: clinical spectrum and genotype-phenotype correlations","volume":"68","author":"Valstar","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.joca.2013.08.001_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2011.06.097","article-title":"Cardiovascular manifestations of mucopolysaccharidosis type VI (Maroteaux\u2013Lamy syndrome)","volume":"158","author":"Golda","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.joca.2013.08.001_bib7","first-page":"129","article-title":"Chondroitin sulfate and growth factor signaling in the skeleton: possible links to MPS VI","volume":"3","author":"Alliston","year":"2010","journal-title":"J\u00a0Pediatr Rehabil Med"},{"key":"10.1016\/j.joca.2013.08.001_bib8","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/ard.2008.095315","article-title":"Musculoskeletal manifestations of lysosomal storage disorders","volume":"68","author":"Aldenhoven","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2013.08.001_bib9","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.bbadis.2011.07.013","article-title":"Bone, joint and tooth development in mucopolysaccharidoses: relevance to therapeutic options","volume":"1812","author":"Oussoren","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.joca.2013.08.001_bib10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/ar3375","article-title":"Osteoimmunology and osteoporosis","volume":"13","author":"Geusens","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2013.08.001_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/ar3323","article-title":"Regulation of bone by the adaptive immune system in arthritis","volume":"13","author":"Okamoto","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2013.08.001_bib12","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI46262","article-title":"Osteoimmunology at the nexus of arthritis, osteoporosis, cancer, and infection","volume":"121","author":"Jones","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.joca.2013.08.001_bib13","doi-asserted-by":"crossref","first-page":"25103","DOI":"10.1074\/jbc.R109.041087","article-title":"Cellular and molecular mechanisms of bone remodeling","volume":"285","author":"Raggatt","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.joca.2013.08.001_bib14","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1747-0285.2008.00741.x","article-title":"The structure of glycosaminoglycans and their interactions with proteins","volume":"72","author":"Gandhi","year":"2008","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.joca.2013.08.001_bib15","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/labinvest.3780345","article-title":"Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses","volume":"81","author":"Simonaro","year":"2001","journal-title":"Lab Invest"},{"key":"10.1016\/j.joca.2013.08.001_bib16","doi-asserted-by":"crossref","first-page":"14362","DOI":"10.1073\/pnas.222536599","article-title":"Glycosaminoglycans are a potential cause of rheumatoid arthritis","volume":"99","author":"Wang","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.joca.2013.08.001_bib17","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.joca.2013.08.001_bib18","first-page":"459","article-title":"Inflammation and metabolic disorders","volume":"11","author":"Navab","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.joca.2013.08.001_bib19","first-page":"642612","article-title":"Lipid chaperones and metabolic inflammation","volume":"2011","author":"Furuhashi","year":"2011","journal-title":"Int J Inflam"},{"key":"10.1016\/j.joca.2013.08.001_bib20","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/jnr.21912","article-title":"Innate and adaptive immune activation in the brain of MPS IIIB mouse model","volume":"87","author":"DiRosario","year":"2009","journal-title":"J\u00a0Neurosci Res"},{"key":"10.1016\/j.joca.2013.08.001_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1742-2094-7-39","article-title":"Mucopolysaccharidosis IIIB, a lysosomal storage disease, triggers a pathogenic CNS autoimmune response","volume":"7","author":"Killedar","year":"2010","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.joca.2013.08.001_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1755-8417-2-4","article-title":"Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI","volume":"2","author":"Tessitore","year":"2009","journal-title":"Pathogenetics"},{"key":"10.1016\/j.joca.2013.08.001_bib23","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1073\/pnas.0912937107","article-title":"Involvement of the Toll-like receptor 4 pathway and use of TNF-alpha antagonists for treatment of the mucopolysaccharidoses","volume":"107","author":"Simonaro","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.joca.2013.08.001_bib24","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"Simonaro","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.joca.2013.08.001_bib25","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2353\/ajpath.2008.070564","article-title":"Mechanism of glycosaminoglycan-mediated bone and joint disease: implications for the mucopolysaccharidoses and other connective tissue diseases","volume":"172","author":"Simonaro","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joca.2013.08.001_bib26","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.addr.2004.12.013","article-title":"The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics","volume":"57","author":"Yasuda","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.joca.2013.08.001_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s002239900656","article-title":"Histomorphometric analysis of the tibial growth plate in a feline model of mucopolysaccharidosis type VI","volume":"65","author":"Nuttall","year":"1999","journal-title":"Calcified Tissue Int"},{"key":"10.1016\/j.joca.2013.08.001_bib28","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2353\/ajpath.2009.090211","article-title":"Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities","volume":"175","author":"Wilson","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.joca.2013.08.001_bib29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bone.2013.03.014","article-title":"Postnatal progression of bone disease in the cervical spines of mucopolysaccharidosis I dogs","volume":"55","author":"Chiaro","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.joca.2013.08.001_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/iep.12033","article-title":"Characterization of joint disease in mucopolysaccharidosis type I mice","author":"de Oliveira","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.joca.2013.08.001_bib31","first-page":"305","article-title":"Hurler syndrome with special reference to histologic abnormalities of the growth plate","author":"Silveri","year":"1991","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.joca.2013.08.001_bib32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3109\/00313028609059462","article-title":"The histological and ultrastructural features of the epiphyseal plate in Morquio type A syndrome (mucopolysaccharidosis type IVA)","volume":"18","author":"McClure","year":"1986","journal-title":"Pathology"},{"key":"10.1016\/j.joca.2013.08.001_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.arthro.2004.09.025","article-title":"Arthroscopic and histologic findings in Morquio's syndrome","volume":"21","author":"Kalteis","year":"2005","journal-title":"Arthroscopy"},{"key":"10.1016\/j.joca.2013.08.001_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ymgme.2009.03.005","article-title":"Mechanism of shortened bones in mucopolysaccharidosis VII","volume":"97","author":"Metcalf","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.joca.2013.08.001_bib35","doi-asserted-by":"crossref","first-page":"e22447","DOI":"10.1371\/journal.pone.0022447","article-title":"Anti-TNF-alpha therapy enhances the effects of enzyme replacement therapy in rats with mucopolysaccharidosis type VI","volume":"6","author":"Eliyahu","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.joca.2013.08.001_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00310256","article-title":"Growth plate pathology in feline mucopolysaccharidosis VI","volume":"57","author":"Abreu","year":"1995","journal-title":"Calcified Tissue Int"},{"key":"10.1016\/j.joca.2013.08.001_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10545-012-9522-x","article-title":"Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII","volume":"36","author":"Rowan","year":"2013","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.joca.2013.08.001_bib38","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10545-005-5673-3","article-title":"Keratan sulphate levels in mucopolysaccharidoses and mucolipidoses","volume":"28","author":"Tomatsu","year":"2005","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.joca.2013.08.001_bib39","first-page":"25","article-title":"Growth patterns and the use of growth hormone in the mucopolysaccharidoses","volume":"3","author":"Polgreen","year":"2010","journal-title":"J\u00a0Pediatr Rehabil Med"},{"key":"10.1016\/j.joca.2013.08.001_bib40","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1651-2227.2010.02060.x","article-title":"Growth pattern and growth prediction of body height in children with mucopolysaccharidosis type II","volume":"100","author":"Rozdzynska","year":"2011","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.joca.2013.08.001_bib41","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ymgme.2009.08.008","article-title":"Anthropometric data of 14 patients with mucopolysaccharidosis I: retrospective analysis and efficacy of recombinant human alpha-L-iduronidase (laronidase)","volume":"99","author":"Tylki-Szymanska","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.joca.2013.08.001_bib42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S8756-3282(97)00175-0","article-title":"Effect of enzyme replacement therapy on bone formation in a feline model of mucopolysaccharidosis type VI","volume":"21","author":"Byers","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.joca.2013.08.001_bib43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/8756-3282(95)00333-4","article-title":"Bone changes in mucopolysaccharidosis VI in cats and the effects of bone marrow transplantation: mechanical testing of long bones","volume":"17","author":"Norrdin","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.joca.2013.08.001_bib44","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0002-9440(10)64961-9","article-title":"Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly","volume":"156","author":"Hinek","year":"2000","journal-title":"Am J Pathol"},{"issue":"Suppl 5","key":"10.1016\/j.joca.2013.08.001_bib45","doi-asserted-by":"crossref","first-page":"v13","DOI":"10.1093\/rheumatology\/ker395","article-title":"Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator","volume":"50","author":"Clarke","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.joca.2013.08.001_bib46","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/ar2592","article-title":"Cartilage homeostasis in health and rheumatic diseases","volume":"11","author":"Goldring","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2013.08.001_bib47","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1089\/scd.2011.0555","article-title":"Hurler disease bone marrow stromal cells exhibit altered ability to support osteoclast formation","volume":"21","author":"Gatto","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.joca.2013.08.001_bib48","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S8756-3282(01)00679-2","article-title":"Abnormal osteoclast morphology and bone remodeling in a murine model of a lysosomal storage disease","volume":"30","author":"Monroy","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.joca.2013.08.001_bib49","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A\u00a0road map for those who don't know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.joca.2013.08.001_bib50","first-page":"1650","article-title":"The Jak-STAT pathway in rheumatoid arthritis","volume":"32","author":"Walker","year":"2005","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.joca.2013.08.001_bib51","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/8756-3282(93)90165-7","article-title":"Characterization of osteopenia in feline mucopolysaccharidosis VI and evaluation of bone marrow transplantation therapy","volume":"14","author":"Norrdin","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.joca.2013.08.001_bib52","article-title":"Low bone mineral content and challenges in interpretation of dual-energy X-ray absorptiometry in children with mucopolysaccharidosis types I, II, and VI","author":"Polgreen","year":"2013","journal-title":"J\u00a0Clin Densitom"},{"key":"10.1016\/j.joca.2013.08.001_bib53","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/qjmed\/hch041","article-title":"Secondary skeletal involvement in Sanfilippo syndrome","volume":"97","author":"Rigante","year":"2004","journal-title":"QJM"},{"key":"10.1016\/j.joca.2013.08.001_bib54","first-page":"13","article-title":"Bone density assessment in patients with mucopolysaccharidosis: a preliminary report from patients with MPS II and VI","volume":"3","author":"Fung","year":"2010","journal-title":"J\u00a0Pediatr Rehabil Med"},{"key":"10.1016\/j.joca.2013.08.001_bib55","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ymgme.2012.05.003","article-title":"Biomarkers for the mucopolysaccharidoses: discovery and clinical utility","volume":"106","author":"Clarke","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.joca.2013.08.001_bib56","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/ar2571","article-title":"Osteoimmunology in rheumatic diseases","volume":"11","author":"Schett","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.joca.2013.08.001_bib57","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","article-title":"Neutrophil function in inflammation and inflammatory diseases","volume":"49","author":"Wright","year":"2010","journal-title":"Rheumatology"},{"issue":"Suppl 5","key":"10.1016\/j.joca.2013.08.001_bib58","doi-asserted-by":"crossref","first-page":"v49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","volume":"50","author":"Valayannopoulos","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.joca.2013.08.001_bib59","first-page":"443","article-title":"Enzyme replacement therapy with galsulfase for mucopolysaccharidosis VI: clinical facts and figures","volume":"52","author":"Harmatz","year":"2010","journal-title":"Turkish J Pediatr"},{"key":"10.1016\/j.joca.2013.08.001_bib60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10545-010-9059-9","article-title":"Efficacy of recombinant human alpha-L-iduronidase (laronidase) on restricted range of motion of upper extremities in mucopolysaccharidosis type I patients","volume":"33","author":"Tylki-Szymanska","year":"2010","journal-title":"J\u00a0Inherit Metab Dis"},{"key":"10.1016\/j.joca.2013.08.001_bib61","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1111\/j.1651-2227.2011.02385.x","article-title":"Enzyme replacement therapy for mucopolysaccharidosis II from 3 months of age: 3-year follow-up","volume":"101","author":"Tylki-Szymanska","year":"2012","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.joca.2013.08.001_bib62","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1172\/JCI119208","article-title":"Enzyme replacement therapy from birth in a feline model of mucopolysaccharidosis type VI","volume":"99","author":"Crawley","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.joca.2013.08.001_bib63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ymgme.2010.09.010","article-title":"Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI","volume":"102","author":"Turbeville","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.joca.2013.08.001_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/BC.2008.009","article-title":"A\u00a0counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity","volume":"389","author":"Fan","year":"2008","journal-title":"Biol Chem"},{"key":"10.1016\/j.joca.2013.08.001_bib65","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/sj.ejhg.5201623","article-title":"Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses","volume":"14","author":"Piotrowska","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.joca.2013.08.001_bib66","doi-asserted-by":"crossref","first-page":"CR196","DOI":"10.12659\/MSM.881715","article-title":"Two-year follow-up of Sanfilippo disease patients treated with a genistein-rich isoflavone extract: assessment of effects on cognitive functions and general status of patients","volume":"17","author":"Piotrowska","year":"2011","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.joca.2013.08.001_bib67","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.curtheres.2008.04.002","article-title":"Genistin-rich soy isoflavone extract in substrate reduction therapy for Sanfilippo syndrome: an open label, pilot study in 10 pediatric patients","volume":"69","author":"Piotrowska","year":"2008","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.joca.2013.08.001_bib68","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1423-0127-16-26","article-title":"Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway","volume":"16","author":"Jakobkiewicz-Banecka","year":"2009","journal-title":"J\u00a0Biomed Sci"},{"key":"10.1016\/j.joca.2013.08.001_bib69","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1042\/BST0380695","article-title":"Genistein: a natural isoflavone with a potential for treatment of genetic diseases","volume":"38","author":"Wegrzyn","year":"2010","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.joca.2013.08.001_bib70","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/iub.1007","article-title":"Gene expression-targeted isoflavone therapy","volume":"64","author":"Wegrzyn","year":"2012","journal-title":"IUBMB Life"},{"key":"10.1016\/j.joca.2013.08.001_bib71","doi-asserted-by":"crossref","first-page":"e14192","DOI":"10.1371\/journal.pone.0014192","article-title":"Genistein improves neuropathology and corrects behaviour in a mouse model of neurodegenerative metabolic disease","volume":"5","author":"Malinowska","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.joca.2013.08.001_bib72","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1002\/ajmg.a.34146","article-title":"Improvement in the range of joint motion in seven patients with mucopolysaccharidosis type II during experimental gene expression-targeted isoflavone therapy (GET IT)","volume":"155A","author":"Marucha","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.joca.2013.08.001_bib73","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.2006-2184","article-title":"Management guidelines for mucopolysaccharidosis VI","volume":"120","author":"Giugliani","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.joca.2013.08.001_bib74","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.semarthrit.2008.08.001","article-title":"Nonsteroidal anti-inflammatory drugs: adverse effects and their prevention","volume":"39","author":"Vonkeman","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.joca.2013.08.001_bib75","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2012.10.014","article-title":"Tumor necrosis factor","volume":"328","author":"Chu","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.joca.2013.08.001_bib76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2008-0416","article-title":"Mucopolysaccharidosis I: management and treatment guidelines","volume":"123","author":"Muenzer","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.joca.2013.08.001_bib77","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.rdc.2010.03.003","article-title":"Bone damage in rheumatoid arthritis: mechanistic insights and approaches to prevention","volume":"36","author":"Karmakar","year":"2010","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.joca.2013.08.001_bib78","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/acr.20004","article-title":"Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients","volume":"62","author":"Deodhar","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.joca.2013.08.001_bib79","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","article-title":"Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)","volume":"186","author":"Ghoreschi","year":"2011","journal-title":"J\u00a0Immunol"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458413009047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458413009047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:30:37Z","timestamp":1761017437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458413009047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":79,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S1063458413009047"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2013.08.001","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoimmunology in mucopolysaccharidoses type I, II, VI and VII. Immunological regulation of the osteoarticular system in the course of\u00a0metabolic inflammation","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2013.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}